Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 GeneticVariation disease BEFREE The Timothy syndrome mutation is a rare de novo gain-of-function variant in CACNA1C that causes autism with high penetrance, providing a powerful avenue into investigating the role of CACNA1C variants in neurodevelopmental disorders. 31805042 2019
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.030 GeneticVariation disease BEFREE To uncover a possible relationship between VDR genotype and clinical conditions in TS patients, we investigated two functional VDR variants (Cdx-2 and FokI) for allele and genotype frequencies, as well as expression profile in TS individuals versus healthy controls (HC). 31686401 2020
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 Biomarker disease BEFREE The majority of P/LP variants in patients with CACNA1C-mediated LQT8 cluster in an SH3-binding domain of the cytosolic II-III loop. 31408100 2019
Entrez Id: 23322
Gene Symbol: RPGRIP1L
RPGRIP1L
0.010 Biomarker disease BEFREE Laterally deviated eccentric circular type mastectomy may be a good option for FTM TS patients who have moderately sized breasts with such features. 31144007 2019
Entrez Id: 57822
Gene Symbol: GRHL3
GRHL3
0.010 Biomarker disease BEFREE TS significantly increased soil SOM at depths of 20 cm and 30 cm. 29930282 2018
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 GeneticVariation disease BEFREE To our knowledge, this patient is the first to exhibit syndactyly and to carry a CACNA1C mutation but to not have QT prolongation, which has long been considered an obligatory feature of Timothy syndrome. 29736926 2018
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 Biomarker disease GENOMICS_ENGLAND Emerging therapeutic targets in the short QT syndrome. 29697308 2018
Entrez Id: 2688
Gene Symbol: GH1
GH1
0.030 Biomarker disease BEFREE This study aimed to systematically review the available literature on "quality of life" (QoL) or "health-related quality of life" (HRQoL) in Turner syndrome (TS) patients and to analyze the relations among height, puberty, and the use of growth hormone (GH) and the QoL of TS patients. 29427215 2018
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 GeneticVariation disease BEFREE The Shank3 models mimick gene mutations associated with Phelan-McDermid Syndrome and the Cacna1c model recapitulates the deletion underlying Timothy syndrome. 28753255 2018
Entrez Id: 85358
Gene Symbol: SHANK3
SHANK3
0.010 GeneticVariation disease BEFREE The Shank3 models mimick gene mutations associated with Phelan-McDermid Syndrome and the Cacna1c model recapitulates the deletion underlying Timothy syndrome. 28753255 2018
Entrez Id: 1020
Gene Symbol: CDK5
CDK5
0.010 Biomarker disease BEFREE Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome. 28648896 2017
Entrez Id: 7248
Gene Symbol: TSC1
TSC1
0.010 GeneticVariation disease BEFREE TS pathology is caused by mutations in tuberous sclerosis complex (TSC) genes and is associated with insulin resistance, decreased glycogen synthase kinase 3β (GSK3β) activity, activation of the mammalian target of rapamycin complex 1 (mTORC1), and subsequent increase in protein synthesis. 28646232 2017
Entrez Id: 6559
Gene Symbol: SLC12A3
SLC12A3
0.010 GeneticVariation disease BEFREE TS pathology is caused by mutations in tuberous sclerosis complex (TSC) genes and is associated with insulin resistance, decreased glycogen synthase kinase 3β (GSK3β) activity, activation of the mammalian target of rapamycin complex 1 (mTORC1), and subsequent increase in protein synthesis. 28646232 2017
Entrez Id: 54997
Gene Symbol: TESC
TESC
0.010 GeneticVariation disease BEFREE TS pathology is caused by mutations in tuberous sclerosis complex (TSC) genes and is associated with insulin resistance, decreased glycogen synthase kinase 3β (GSK3β) activity, activation of the mammalian target of rapamycin complex 1 (mTORC1), and subsequent increase in protein synthesis. 28646232 2017
Entrez Id: 2932
Gene Symbol: GSK3B
GSK3B
0.010 GeneticVariation disease BEFREE TS pathology is caused by mutations in tuberous sclerosis complex (TSC) genes and is associated with insulin resistance, decreased glycogen synthase kinase 3β (GSK3β) activity, activation of the mammalian target of rapamycin complex 1 (mTORC1), and subsequent increase in protein synthesis. 28646232 2017
Entrez Id: 2875
Gene Symbol: GPT
GPT
0.010 Biomarker disease BEFREE In the present study, we first confirmed that the serum levels of aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase, biochemical markers of liver function, were altered in rats under tail suspension (TS) conditions to simulate microgravity, as shown in previous reports. 28642576 2017
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 Biomarker disease GENOMICS_ENGLAND A multicentre study of patients with Timothy syndrome. 28371864 2018
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 Biomarker disease BEFREE TRPM4 enlarges the subgroup of LQT genes (KCNJ2 in Andersen syndrome and CACNA1C in Timothy syndrome) known to increase the QT interval through a more complex pleiotropic effect than merely action potential alteration. 28315637 2017
Entrez Id: 3784
Gene Symbol: KCNQ1
KCNQ1
0.010 GeneticVariation disease BEFREE TRPM4 enlarges the subgroup of LQT genes (KCNJ2 in Andersen syndrome and CACNA1C in Timothy syndrome) known to increase the QT interval through a more complex pleiotropic effect than merely action potential alteration. 28315637 2017
Entrez Id: 3759
Gene Symbol: KCNJ2
KCNJ2
0.010 Biomarker disease BEFREE TRPM4 enlarges the subgroup of LQT genes (KCNJ2 in Andersen syndrome and CACNA1C in Timothy syndrome) known to increase the QT interval through a more complex pleiotropic effect than merely action potential alteration. 28315637 2017
Entrez Id: 708
Gene Symbol: C1QBP
C1QBP
0.010 Biomarker disease BEFREE Given the fact that tactile stimulation (TS) treatment has been previously shown to be an effective therapeutic approach and with potential application to humans, here we ask whether exposure to TS treatment, from postnatal day (P) 1 to P32 for 3min/day, could also be employed to prevent neuroanatomical changes in the optic nerve of rats maintained on an iron-deficient diet during brain development. 27956122 2017
Entrez Id: 925
Gene Symbol: CD8A
CD8A
0.010 Biomarker disease BEFREE Given the fact that tactile stimulation (TS) treatment has been previously shown to be an effective therapeutic approach and with potential application to humans, here we ask whether exposure to TS treatment, from postnatal day (P) 1 to P32 for 3min/day, could also be employed to prevent neuroanatomical changes in the optic nerve of rats maintained on an iron-deficient diet during brain development. 27956122 2017
Entrez Id: 3622
Gene Symbol: ING2
ING2
0.010 Biomarker disease BEFREE Given the fact that tactile stimulation (TS) treatment has been previously shown to be an effective therapeutic approach and with potential application to humans, here we ask whether exposure to TS treatment, from postnatal day (P) 1 to P32 for 3min/day, could also be employed to prevent neuroanatomical changes in the optic nerve of rats maintained on an iron-deficient diet during brain development. 27956122 2017
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 GeneticVariation disease BEFREE Incomplete Timothy syndrome secondary to a mosaic mutation of the CACNA1C gene diagnosed using next-generation sequencing. 27868338 2017
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 GeneticVariation disease BEFREE Timothy syndrome (TS) is a congenital long QT syndrome that is associated with syndactyly and mutations in CACNA1C, encoding an L-type voltage-dependent calcium channel, Cav1.2. 27593853 2016